FindTrial
Sign In

Protein Profile and Clinical Implications of Atrial Tissue in Ischemia-Reperfusion Injury

Protein Profile and Clinical Implications of Atrial Tissue in Ischemia-Reperfusion Injury

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116502
Enrollment
Unknown
Registered
2026-01-12
Start date
2026-01-20
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative atrial fibrillation (POAF)

Interventions

Observation group:None

Sponsors

The Second Affiliated Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients undergoing their first elective coronary artery bypass grafting (CABG) and/or valve replacement surgery with cardiopulmonary bypass (CPB). 2.Aged 18 years or older; 3.Signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.History of pacemaker implantation and coronary stent implantation. 2.History of arrhythmia; 3.Paired specimens could not be obtained during the surgery. 4.Emergency surgery;

Design outcomes

Primary

MeasureTime frame
Protein expression;Incidence of Atrial Fibrillation after CPB;—

Secondary

MeasureTime frame
Patient baseline characteristics;Medication Use During the Perioperative Period;Workup, results, and diagnosis during hospitalization.;—

Countries

China

Contacts

Public ContactLiangqing Zhang

The Second Affiliated Hospital of Guangdong Medical University

febright@126.com+86 759 2372349

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026